Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02843074 |
| Title | Elotuzumab, Lenalidomide and Dexamethasone (ERd) in the Induction, Consolidation and Maintenance Treatment of Transplant-Eligible, Newly Diagnosed Multiple Myeloma Patients |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | SCRI Development Innovations, LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Colorado Blood Cancer Institute | Denver | Colorado | 80218 | United States | Details | |
| Center for Cancer and Blood Disorders | Bethesda | Maryland | 20817 | United States | Details | |
| HCA Midwest Health/Research Medical Center | Kansas City | Missouri | 64132 | United States | Details | |
| Nebraska Methodist Hospital | Omaha | Nebraska | 68114 | United States | Details | |
| Tennessee Oncology | Chattanooga | Tennessee | 37404 | United States | Details | |
| Tennessee Oncology | Nashville | Tennessee | 37203 | United States | Details |